IE891149L - Ultrasonic contrast medium - Google Patents

Ultrasonic contrast medium

Info

Publication number
IE891149L
IE891149L IE891149A IE114989A IE891149L IE 891149 L IE891149 L IE 891149L IE 891149 A IE891149 A IE 891149A IE 114989 A IE114989 A IE 114989A IE 891149 L IE891149 L IE 891149L
Authority
IE
Ireland
Prior art keywords
contrast medium
ultrasonic contrast
microparticles
ultrasonic
myocardium
Prior art date
Application number
IE891149A
Other versions
IE65243B1 (en
Inventor
Lothar Prof Lange
Jurgen Hilmann
Thomas Dr Fritysch
Joachim Dr Siegert
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of IE891149L publication Critical patent/IE891149L/en
Publication of IE65243B1 publication Critical patent/IE65243B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3925—Markers, e.g. radio-opaque or breast lesions markers ultrasonic

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Acoustics & Sound (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Fats And Perfumes (AREA)
  • Junction Field-Effect Transistors (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Gyroscopes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Air Conditioning Control Device (AREA)

Abstract

Contrast agents for ultrasonic diagnosis consisting of gas bubbles and microparticles are described and are characterised in that they contain as microparticles a mixture of at least one (C10-C20)-fatty acid with at least one solid which has no interfacial activity, suspended in a liquid vehicle. They provide contrast in ultrasonic imaging of the right and left heart, the myocardium and other organs such as the liver, spleen and kidney, after intravenous administration.
IE114989A 1988-10-07 1989-04-11 Ultrasonic contrast medium made up of small gas bubbles and fatty-acid-containing microparticles IE65243B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3834705A DE3834705A1 (en) 1988-10-07 1988-10-07 ULTRASONIC CONTRASTING AGENTS FROM GAS BUBBLES AND MICROPARTICLES CONTAINING FATTY ACID

Publications (2)

Publication Number Publication Date
IE891149L true IE891149L (en) 1990-04-07
IE65243B1 IE65243B1 (en) 1995-10-04

Family

ID=6364930

Family Applications (1)

Application Number Title Priority Date Filing Date
IE114989A IE65243B1 (en) 1988-10-07 1989-04-11 Ultrasonic contrast medium made up of small gas bubbles and fatty-acid-containing microparticles

Country Status (19)

Country Link
EP (1) EP0365467B1 (en)
JP (1) JPH0737394B2 (en)
KR (1) KR970001433B1 (en)
CN (1) CN1027575C (en)
AT (1) ATE93145T1 (en)
AU (1) AU627456B2 (en)
CA (1) CA1338507C (en)
DE (2) DE3834705A1 (en)
DK (1) DK99789A (en)
ES (1) ES2059814T3 (en)
FI (1) FI100170B (en)
IE (1) IE65243B1 (en)
IL (1) IL90028A (en)
LU (1) LU90004I2 (en)
NL (1) NL970009I2 (en)
NO (2) NO178139C (en)
NZ (1) NZ228781A (en)
PT (1) PT91523B (en)
ZA (1) ZA892885B (en)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5607661A (en) * 1991-07-05 1997-03-04 Nycomed Imaging As Aggregates of x-ray microparticles for ultrasound imaging
MX9205298A (en) 1991-09-17 1993-05-01 Steven Carl Quay GASEOUS ULTRASOUND CONTRASTING MEDIA AND METHOD FOR SELECTING GASES TO BE USED AS ULTRASOUND CONTRASTING MEDIA
DK0605477T4 (en) * 1991-09-17 2007-10-01 Ge Healthcare As Gaseous ultrasound contrast agents
US6723303B1 (en) 1991-09-17 2004-04-20 Amersham Health, As Ultrasound contrast agents including protein stabilized microspheres of perfluoropropane, perfluorobutane or perfluoropentane
US5409688A (en) * 1991-09-17 1995-04-25 Sonus Pharmaceuticals, Inc. Gaseous ultrasound contrast media
US5196183A (en) * 1991-12-04 1993-03-23 Sterling Winthrop Inc. Contrast agents for ultrasound imaging
GB9200388D0 (en) * 1992-01-09 1992-02-26 Nycomed As Improvements in or relating to contrast agents
GB9200387D0 (en) * 1992-01-09 1992-02-26 Nycomed As Improvements in or relating to contrast agents
PL176116B1 (en) 1993-01-25 1999-04-30 Sonus Pharma Inc Colloidal suspensions able to undergo phase transitions for use as usg contrast media
US5558855A (en) * 1993-01-25 1996-09-24 Sonus Pharmaceuticals Phase shift colloids as ultrasound contrast agents
IL108416A (en) 1993-01-25 1998-10-30 Sonus Pharma Inc Phase shift colloids as ultrasound contrast agents
GB9402867D0 (en) * 1994-02-15 1994-04-06 Nycomed Imaging As Improvements in or relating to contrast agents
DE4406474A1 (en) 1994-02-23 1995-08-24 Schering Ag Gas-containing microparticles, agents containing them, their use in ultrasound diagnostics, and methods for producing the particles and agents
US5876697A (en) * 1994-08-04 1999-03-02 Gakko Houjin Toin Gakuen Method for the production of microbubble-type ultrasonic contrast agent using fatty acid surfactants
DE19602930A1 (en) * 1996-01-18 1997-07-24 Schering Ag Porous matrices made of low molecular weight substances for the generation of stable gas bubble suspensions, their use as ultrasound contrast agents and processes for their production
GB9808582D0 (en) * 1998-04-22 1998-06-24 Nycomed Imaging As Improvements in or relating to contrast agents
AU1705300A (en) 1998-10-12 2000-05-01 Mallinckrodt, Inc. Novel ultrasound contrast agents
DE19950311A1 (en) * 1999-10-13 2001-04-19 Schering Ag Stable storage of parenteral ultrasonic contrast agent formulation, using vial closed with dry stopper to prevent reduction of in vivo effectiveness
DE19952738A1 (en) * 1999-10-27 2001-05-23 Schering Ag Improved suspensions of ultrasound contrast media
EP2286843A3 (en) 2000-06-02 2011-08-03 Bracco Suisse SA Compounds for targeting endothelial cells
WO2002080774A2 (en) 2001-04-06 2002-10-17 Bracco Research S.A. Method for improved measurement of local physical parameters in afluid-filled cavity
US7211240B2 (en) 2002-03-01 2007-05-01 Bracco International B.V. Multivalent constructs for therapeutic and diagnostic applications
EP1587944A4 (en) 2002-03-01 2007-03-21 Dyax Corp Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
US8623822B2 (en) 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
US7794693B2 (en) 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
ES2398393T3 (en) 2002-03-01 2013-03-15 Dyax Corp. KDR and VEGF / KDR binding peptides and their use in diagnosis and therapy
US7462366B2 (en) 2002-03-29 2008-12-09 Boston Scientific Scimed, Inc. Drug delivery particle
US7842377B2 (en) 2003-08-08 2010-11-30 Boston Scientific Scimed, Inc. Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
US8012454B2 (en) 2002-08-30 2011-09-06 Boston Scientific Scimed, Inc. Embolization
US7883490B2 (en) 2002-10-23 2011-02-08 Boston Scientific Scimed, Inc. Mixing and delivery of therapeutic compositions
DK2949658T3 (en) 2003-03-03 2018-10-01 Dyax Corp Peptides that specifically bind HGF receptor (cMet) and uses thereof
US7976823B2 (en) 2003-08-29 2011-07-12 Boston Scientific Scimed, Inc. Ferromagnetic particles and methods
US7901770B2 (en) 2003-11-04 2011-03-08 Boston Scientific Scimed, Inc. Embolic compositions
KR101001547B1 (en) 2004-01-28 2010-12-17 삼성에스디아이 주식회사 A fabric solar cell and a method for preparing the same
US7736671B2 (en) 2004-03-02 2010-06-15 Boston Scientific Scimed, Inc. Embolization
US8173176B2 (en) 2004-03-30 2012-05-08 Boston Scientific Scimed, Inc. Embolization
US7311861B2 (en) 2004-06-01 2007-12-25 Boston Scientific Scimed, Inc. Embolization
US8012457B2 (en) 2004-06-04 2011-09-06 Acusphere, Inc. Ultrasound contrast agent dosage formulation
US8425550B2 (en) 2004-12-01 2013-04-23 Boston Scientific Scimed, Inc. Embolic coils
US7727555B2 (en) 2005-03-02 2010-06-01 Boston Scientific Scimed, Inc. Particles
US7858183B2 (en) 2005-03-02 2010-12-28 Boston Scientific Scimed, Inc. Particles
US7963287B2 (en) 2005-04-28 2011-06-21 Boston Scientific Scimed, Inc. Tissue-treatment methods
US9463426B2 (en) 2005-06-24 2016-10-11 Boston Scientific Scimed, Inc. Methods and systems for coating particles
US8007509B2 (en) 2005-10-12 2011-08-30 Boston Scientific Scimed, Inc. Coil assemblies, components and methods
US8152839B2 (en) 2005-12-19 2012-04-10 Boston Scientific Scimed, Inc. Embolic coils
US8101197B2 (en) 2005-12-19 2012-01-24 Stryker Corporation Forming coils
US7947368B2 (en) 2005-12-21 2011-05-24 Boston Scientific Scimed, Inc. Block copolymer particles
US8414927B2 (en) 2006-11-03 2013-04-09 Boston Scientific Scimed, Inc. Cross-linked polymer particles
JP5196896B2 (en) * 2007-07-13 2013-05-15 花王株式会社 Method for producing fine bubble precursor
WO2021141595A1 (en) * 2020-01-10 2021-07-15 Advanced Microbubbles Laboratories Llc Preparation and preservation of collagen microbubbles

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3640271A (en) 1969-06-30 1972-02-08 Ibm Blood flow pressure measurement technique employing injected bubbled and ultrasonic frequency scanning
US4276885A (en) 1979-05-04 1981-07-07 Rasor Associates, Inc Ultrasonic image enhancement
US4265251A (en) 1979-06-28 1981-05-05 Rasor Associates, Inc. Method of determining pressure within liquid containing vessel
CA1170569A (en) 1980-11-17 1984-07-10 Julia S. Rasor Microbubble precursors and methods for their production and use
DE3141641A1 (en) 1981-10-16 1983-04-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen ULTRASONIC CONTRAST AGENTS AND THEIR PRODUCTION
JPS5920532A (en) * 1982-07-23 1984-02-02 Nippon Denso Co Ltd Method of controlling quantity of fuel for internal combustion engine on vehicle
DE3313946A1 (en) 1983-04-15 1984-10-18 Schering AG, 1000 Berlin und 4709 Bergkamen MICROPARTICLES AND GAS BUBBLES CONTAINING ULTRASONIC CONTRASTING AGENTS
DE3313947A1 (en) * 1983-04-15 1984-10-18 Schering AG, 1000 Berlin und 4709 Bergkamen MICROPARTICLES AND GAS BUBBLES CONTAINING ULTRASONIC CONTRASTING AGENTS
DE3637926C1 (en) * 1986-11-05 1987-11-26 Schering Ag Ultrasonic manometry in a liquid using microbubbles

Also Published As

Publication number Publication date
ES2059814T3 (en) 1994-11-16
PT91523A (en) 1990-04-30
AU627456B2 (en) 1992-08-27
NO1998014I1 (en) 1998-05-05
NO178139C (en) 1996-01-31
EP0365467A2 (en) 1990-04-25
EP0365467A3 (en) 1990-06-06
IL90028A0 (en) 1989-12-15
FI100170B (en) 1997-10-15
DK99789D0 (en) 1989-03-01
FI890749A (en) 1990-04-08
NL970009I2 (en) 1997-08-01
DE3834705A1 (en) 1990-04-12
CN1044225A (en) 1990-08-01
CA1338507C (en) 1996-08-06
DK99789A (en) 1990-04-08
JPH0737394B2 (en) 1995-04-26
ATE93145T1 (en) 1993-09-15
DE58905318D1 (en) 1993-09-23
IL90028A (en) 1993-01-31
FI890749A0 (en) 1989-02-16
NO890609L (en) 1990-04-09
PT91523B (en) 1995-05-31
AU3390089A (en) 1990-04-12
NO178139B (en) 1995-10-23
EP0365467B1 (en) 1993-08-18
NZ228781A (en) 1992-03-26
KR900005939A (en) 1990-05-07
LU90004I2 (en) 1997-03-04
JPH02145528A (en) 1990-06-05
NO890609D0 (en) 1989-02-13
CN1027575C (en) 1995-02-08
NL970009I1 (en) 1997-05-01
KR970001433B1 (en) 1997-02-06
IE65243B1 (en) 1995-10-04
ZA892885B (en) 1990-12-28

Similar Documents

Publication Publication Date Title
IE891149L (en) Ultrasonic contrast medium
Walsh et al. Successful treatment of hepatosplenic candidiasis through repeated cycles of chemotherapy and neutropenia
CA2211100A1 (en) Diagnostic imaging contrast agents with extended blood retention
MY134715A (en) Contrast agents for ultrasound imaging
IL97411A (en) Pharmaceutical formulations comprising hapten-modified diagnostic or therapeutic agents
ATE96661T1 (en) SOFT GELATIN CAPSULES AND PROCESS FOR THEIR MANUFACTURE.
FI884051A0 (en) Method for preparing stabilized human protein preparations
NO301829B1 (en) 2-pyridylmethylene polyazamacrocyclophosphonic acids, complexes and pharmaceutical preparations based on these
ES2052766T3 (en) MAGNETIC COMPOSITIONS IN LIQUID STATE.
CA2312915A1 (en) Automatic liquid injection system and method
ATE80801T1 (en) ANTITUMORS COMPOSITIONS CONTAINING A REACTION PRODUCT BETWEEN A CYTOTOXIC ALDEHYDE AND PENICILLAMIN AND THEIR USE IN THE MANUFACTURE OF PHARMACEUTICALS.
Chaudhuri et al. Uptake of 87mSr by liver metastasis from carcinoma of colon
Aramaki et al. Selective incorporation of asialofetuin into hepatocyte of rat
JOHANSSON et al. 6‐Hydroxydopamine and the blood‐brain barrier in adult conscious rats
KR100373712B1 (en) Contrast agent and manufacturing method of same
Skjennald et al. Comparison of iohexol and meglumine-Na-Ca metrizoate in visceral angiography
ALLARD et al. Discordant uptake of technetium-99m DISIDA and technetium-99m sulfur colloid in an amebic abscess
RU95117020A (en) METHOD FOR DIAGNOSIS OF THE ATRIAL DEFECT
Stevens et al. " Structural abnormalities in the frontal system in schizophrenia: A magnetic resonance imaging study": Comment.
SHIH et al. Demonstrating alcoholic cirrhosis of the liver by Tc-99m BIDA scintigram
Jonderko et al. Subacute toxicity of perzotox in rat: Part III. Effect on selected biochemical parameters of blood serum and urine.
XIANG Effect of simulated weightlessness on microvessel permeability of various organs in rabbits
ENEMAS be taught is diminishing, partly as increasing

Legal Events

Date Code Title Description
SPCF Request for grant of supplementary protection certificate

Free format text: SPC 14/96 19960627

SPCG Supplementary protection certificate granted

Free format text: SPC 14/96, 19980128, EXPIRES: 20100409

MM4A Patent lapsed